We are thrilled to invite you to an exclusive opportunity to engage with our leading experts during the upcoming Clinical Trials on Alzheimer's Disease (CTAD) 2024. The CTAD is a conference focused entirely on Alzheimer's Disease Therapeutic Trials, with key leaders in Alzheimer's Disease research from industry and academia coming together to form partnerships aimed at accelerating the development of effective treatments to fight the disease.
Don’t miss out on this unique opportunity to connect with our cross-functional neuroscience team and get insights on customized strategies to help accelerate your timelines and get your therapy to market faster.
